Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Journal Articles

CAMK2G is identified as a novel therapeutic target for myelofibrosis

Masashi Miyauchi, Ken Sasaki, Yuki Kagoya, Kazuki Taoka, Yosuke Masamoto, Sho Yamazaki, Shunya Arai, Hideaki Mizuno, Mineo Kurokawa

Blood Adv (2022) 6 (5): 1585–1597.

https://doi.org/10.1182/bloodadvances.2020003303

Published: 2022

Includes: Supplemental data